HIV News and Research

RSS

Study finds increase in HIV treatment use in the U.S.

Between 2000 and 2008, the proportion of HIV-infected patients in the U.S. receiving effective treatment known as highly active antiretroviral therapy (HAART) increased, and HIV-infected patients appeared to be less infectious and have healthier immune systems at death, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

4 Sep 2012

AIDS experts develop first accurate computer simulation to explain drug effects

Pooling data from thousands of tests of the antiviral activity of more than 20 commonly used anti-HIV drugs, AIDS experts at Johns Hopkins and Harvard universities have developed what they say is the first accurate computer simulation to explain drug effects. Already, the model clarifies how and why some treatment regimens fail in some patients who lack evidence of drug resistance.

3 Sep 2012

Scientists create mathematical model that helps to design new drug cocktails against HIV

For years, doctors treating those with HIV have recognized a relationship between how faithfully patients take the drugs they prescribe, and how likely the virus is to develop drug resistance. More recently, research has shown that the relationship between adherence to a drug regimen and resistance is different for each of the drugs that make up the "cocktail" used to control the disease.

3 Sep 2012

U.S., Nigeria inaugurate Defense Reference Laboratory in Abuja

U.S. Ambassador to Nigeria Terence McCulley spoke on Monday in Abuja at the inauguration of a Defense Reference Laboratory, Leadership reports, noting he said the laboratory, "which is the first of its kind in the sub-region," was supported by U.S. funding.

1 Sep 2012

Reworking of PEPFAR in South Africa must be handled carefully to ensure continuation of care

"Government assurances that the scaling back of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program in South Africa (SA) will be carefully managed to protect patients are welcome, but ... [t]he reality is that the Department of Health is struggling to cope with severe medical staff shortages, financial resources that never seem to stretch far enough, inadequate infrastructure and maintenance programs, and administrative bottlenecks," a Business Day editorial states.

1 Sep 2012

Longer looks: Too many pills for dad; Genetic secrets; A supermarket's dietitian

Job burnout can strike workers in nearly any field, but a new study finds that doctors are at special risk. Nearly 1 in 2 U.S. physicians report at least one symptom of burnout, with doctors at the front line of care particularly vulnerable, the study found -- a significantly higher rate than among the general working population.

1 Sep 2012

Blog examines study looking at role of stigma in HIV PMTCT

The Center for Global Health Policy's "Science Speaks" blog examines a recent study that found only slightly more than 44 percent of women in the Nyanza province of Kenya deliver their infants in a health care facility, with many women citing fear of stigma and discrimination as a reason for not attending clinics for prenatal care.

31 Aug 2012

Brazil expanding national HIV treatment program to include patients with higher CD4 cell counts

Brazil is expanding its national HIV/AIDS treatment program to include about 35,000 additional people, the Associated Press/Seattle Times reports. "Ronaldo Hallal of the health ministry's Sexually Transmitted Disease Department said people with 500 or fewer CD4 cells per cubic millimeter will receive antiretroviral HIV treatment," increasing the cutoff from 350 or less CD4 cells per cubic millimeter prior to the expansion, the news service writes.

31 Aug 2012

Chronic nerve pain: an interview with Professor Sally Lawson

Chronic nerve pain results from pathological changes within a nerve that appear to be self-sustaining and thus the pain continues for a long time.

30 Aug 2012

Researchers identify mechanism that explains link between trichomoniasis and prostate cancer

Researchers have identified a way in which men can develop prostate cancer after contracting trichomoniasis, a curable but often overlooked sexually transmitted disease.

30 Aug 2012

Sleep disorder treatment: an interview with Dr Seth Lederman, President and CEO of Tonix Pharmaceuticals

Sleep disorders are a large area. We are focused on one particular type of sleep disturbance called “non-restorative” sleep. People with this problem do sleep, but they don’t wake up feeling refreshed or feeling that their sleep has had the restorative effects of healthy sleep.

29 Aug 2012

Global Fund, Nigeria sign agreements worth $225M to prevent, treat malaria

The Global Fund to Fight AIDS, Tuberculosis and Malaria and Nigeria on Friday "signed two grant agreements ... worth a total of $225 million to support programs that will prevent and treat malaria," a Global Fund press release reports.

29 Aug 2012

Fear of stigma prevents pregnant women from seeking prenatal care, studies show

Though many pregnant women are aware that treatment could save their lives and the lives of their infants if they test HIV-positive during prenatal care, a new study and literature review have found that a "fear of being stigmatized as an AIDS patient is still a major barrier to good medical care for pregnant young women in many countries," the New York Times reports.

29 Aug 2012

Ethiopian government working to improve access to clean toilets, safe water for people living with HIV

PlusNews examines how a lack of access to clean toilets, safe drinking water, and "information on the prevention of common opportunistic infections means many Ethiopians living with HIV continue to contract easily preventable diseases."

29 Aug 2012

TaiMed, WuXi enter ibalizumab manufacturing agreement

WuXi PharmaTech today announced that it has a contract manufacturing agreement with TaiMed Biologics Inc. for the manufacture of ibalizumab (TMB-355) in support of Phase 2 and Phase 3 clinical trials globally.

29 Aug 2012

American Academy of Pediatrics says circumcision benefits outweigh risks

Shifting its stance, the pediatricians' group now says the benefits of circumcising boys to protect against disease outweighs the risk, but that the decision should be up to parents.

28 Aug 2012

Process for setting new global development goals should be open, inclusive

In this CNN opinion piece, Jamie Drummond, co-founder and executive director of ONE, notes the 2015 deadline for the Millennium Development Goals (MDGs) is approaching, assesses progress towards these goals and examines issues surrounding the creation of a new set of goals.

28 Aug 2012

FDA approves Gilead’s Stribild to treat HIV-1 infection

The U.S. Food and Drug Administration today approved Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate), a new once-a-day combination pill to treat HIV-1 infection in adults who have never been treated for HIV infection.

28 Aug 2012

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

28 Aug 2012

Roundup: Ga. AIDS Drug Assistance waiting list at zero; Mass. signs up for health law's disabled adults program

The state has eliminated a waiting list for a program that provides lifesaving medications to thousands of low-income, uninsured Georgians with HIV/AIDS more than two years after the list was first started. Established in July 2010, the wait list for Georgia's AIDS Drug Assistance Program rapidly ballooned to more than 1,600 -- at one time becoming the largest in the country. A spike in the need for the program was largely fueled by the economic downturn as people lost their jobs and health insurance.

28 Aug 2012

HIV News and Research

Study finds increase in HIV treatment use in the U.S.

AIDS experts develop first accurate computer simulation to explain drug effects

Scientists create mathematical model that helps to design new drug cocktails against HIV

U.S., Nigeria inaugurate Defense Reference Laboratory in Abuja

Reworking of PEPFAR in South Africa must be handled carefully to ensure continuation of care

Longer looks: Too many pills for dad; Genetic secrets; A supermarket's dietitian

Blog examines study looking at role of stigma in HIV PMTCT

Brazil expanding national HIV treatment program to include patients with higher CD4 cell counts

Chronic nerve pain: an interview with Professor Sally Lawson

Researchers identify mechanism that explains link between trichomoniasis and prostate cancer

Sleep disorder treatment: an interview with Dr Seth Lederman, President and CEO of Tonix Pharmaceuticals

Global Fund, Nigeria sign agreements worth $225M to prevent, treat malaria

Fear of stigma prevents pregnant women from seeking prenatal care, studies show

Ethiopian government working to improve access to clean toilets, safe water for people living with HIV

TaiMed, WuXi enter ibalizumab manufacturing agreement

American Academy of Pediatrics says circumcision benefits outweigh risks

Process for setting new global development goals should be open, inclusive

FDA approves Gilead’s Stribild to treat HIV-1 infection

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Roundup: Ga. AIDS Drug Assistance waiting list at zero; Mass. signs up for health law's disabled adults program

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News